Bio-Techne
TECH
294 hedge funds and large institutions have $3.93B invested in Bio-Techne in 2016 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 113 reducing their positions, and 19 closing their positions.
47% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 19
17% more call options, than puts
Call options by funds: $292K | Put options by funds: $249K
2% more funds holding
Funds holding: 288 → 294 (+6)
3.28% less ownership
Funds ownership: 99.54% → 96.26% (-3.3%)
16% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 113
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
43% less capital inflows, than outflows
Capital inflows: $168M | Capital outflows: $295M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fred Alger Management
New York
|
+$21.1M |
| 2 |
Renaissance Technologies
New York
|
+$11.4M |
| 3 |
Millennium Management
New York
|
+$9.6M |
| 4 |
BlackRock Fund Advisors
San Francisco,
California
|
+$8.76M |
| 5 |
Pictet Asset Management (UK)
London,
United Kingdom
|
+$7.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$81M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$79.4M |
| 3 |
QCMC
Quantum Capital Management (California)
San Francisco,
California
|
-$13.5M |
| 4 |
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$12.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$8.07M |
TECH Hedge Fund Activity: Q3 2016 in Review
294 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2016, worth a combined $3.93B — down 6.1% from $4.19B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TECH positions and 19 closed out — a net gain of 9 holders — while 95 added to existing stakes and 113 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $21.1M. The largest seller was Jackson Square Partners, cutting an estimated $81M.
- 294 institutional investors held Bio-Techne (TECH) as of Q3 2016, up from 288 in Q2 2016.
- Funds reported $3.93B of Bio-Techne stock for Q3 2016, down 6.1% quarter-over-quarter.
- 28 funds opened new Bio-Techne positions in Q3 2016 and 19 closed out, a net change of +9 holders.
- The largest Bio-Techne buyer in Q3 2016 was Fred Alger Management, an estimated $21.1M added.
- The largest Bio-Techne seller in Q3 2016 was Jackson Square Partners, an estimated $81M sold.
Based on aggregated 13F filings for Q3 2016.